- Home
- GMM vs ASRT Comparison
GMM vs ASRT Comparison
Compare GMM & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- ASRT
- Stock Information
- Founded
- GMM 2017
- ASRT 1995
- Country
- GMM China
- ASRT United States
- Employees
- GMM N/A
- ASRT N/A
- Industry
- GMM
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- ASRT Health Care
- Exchange
- GMM Nasdaq
- ASRT Nasdaq
- Market Cap
- GMM 70.8M
- ASRT 65.7M
- IPO Year
- GMM 2023
- ASRT 1997
- Fundamental
- Price
- GMM $3.17
- ASRT $0.68
- Analyst Decision
- GMM
- ASRT Strong Buy
- Analyst Count
- GMM 0
- ASRT 3
- Target Price
- GMM N/A
- ASRT $3.08
- AVG Volume (30 Days)
- GMM 33.3K
- ASRT 414.9K
- Earning Date
- GMM 05-16-2025
- ASRT 05-05-2025
- Dividend Yield
- GMM N/A
- ASRT N/A
- EPS Growth
- GMM 62.17
- ASRT N/A
- EPS
- GMM 6.37
- ASRT N/A
- Revenue
- GMM $41,360,953.00
- ASRT $124,961,000.00
- Revenue This Year
- GMM N/A
- ASRT N/A
- Revenue Next Year
- GMM N/A
- ASRT $11.20
- P/E Ratio
- GMM $0.54
- ASRT N/A
- Revenue Growth
- GMM 53.82
- ASRT N/A
- 52 Week Low
- GMM $0.21
- ASRT $0.65
- 52 Week High
- GMM $4.97
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- GMM 35.19
- ASRT 38.24
- Support Level
- GMM $3.02
- ASRT $0.65
- Resistance Level
- GMM $3.49
- ASRT $0.80
- Average True Range (ATR)
- GMM 0.43
- ASRT 0.05
- MACD
- GMM -0.09
- ASRT -0.00
- Stochastic Oscillator
- GMM 9.71
- ASRT 22.00
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.